Juno Pharma Canada Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Debt - Acquisition

  • Financing Rounds
  • 3

  • Investments
  • 5

Juno Pharma Canada General Information

Description

Operator of a pharmaceutical company catering to the healthcare industry. The company focuses on the global development, production, marketing, and distribution of quality, cost-effective injectable and non-injectable medications intended for hospital use.

Contact Information

Formerly Known As
MDA Incorporated, MDA Pharmaceuticals, MDA Pharmaceuticals, Inc., MDA Pharmaceuticals, Incorporated, MDA, Inc., Juno Pharmaceuticals Corp.
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • 11177 Hamon Street
  • Montreal, Quebec H3M 3E4
  • Canada
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Parent Company
Corporate Office
  • 11177 Hamon Street
  • Montreal, Quebec H3M 3E4
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Juno Pharma Canada Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Juno Pharma Canada‘s full profile, request access.

Request a free trial

Juno Pharma Canada Investments & Acquisitions (5)

Juno Pharma Canada’s most recent deal was a Public Investment 2nd Offering with Conavi Medical for . The deal was made on 23-Apr-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Conavi Medical 23-Apr-2025 Public Investment 2nd Offering Diagnostic Equipment
Conavi Medical 08-Oct-2024 Later Stage VC Diagnostic Equipment
FluidAI 20-Jul-2023 Later Stage VC Monitoring Equipment
Omega Laboratories (Drug Delivery) 15-May-2023 Merger/Acquisition Drug Delivery
Contura 01-May-2016 Merger/Acquisition Medical Supplies
To view Juno Pharma Canada’s complete investments and acquisitions history, request access »

Juno Pharma Canada Exits (3)

Juno Pharma Canada’s most recent exit was on 23-Apr-2025 from Conavi Medical. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Conavi Medical 23-Apr-2025 Completed
  • 2 buyers
Conavi Medical 08-Oct-2024 Completed
  • 3 buyers
Contura 01-May-2016 Merger/Acquisition Completed
To view Juno Pharma Canada’s complete exits history, request access »

Juno Pharma Canada Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Omega Laboratories (Drug Delivery) Montreal, Canada 1958

Juno Pharma Canada FAQs

  • When was Juno Pharma Canada founded?

    Juno Pharma Canada was founded in 2012.

  • Where is Juno Pharma Canada headquartered?

    Juno Pharma Canada is headquartered in Montreal, Canada.

  • What industry is Juno Pharma Canada in?

    Juno Pharma Canada’s primary industry is Pharmaceuticals.

  • Is Juno Pharma Canada a private or public company?

    Juno Pharma Canada is a Private company.

  • What is Juno Pharma Canada’s current revenue?

    The current revenue for Juno Pharma Canada is .

  • How much funding has Juno Pharma Canada raised over time?

    Juno Pharma Canada has raised $37.7M.

  • When was Juno Pharma Canada acquired?

    Juno Pharma Canada was acquired on 12-May-2023.

  • Who acquired Juno Pharma Canada?

    Juno Pharma Canada was acquired by Juno Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process